COVID-19 Pandemic Update
ANZSBT has curated a set of resources on the COVID-19 pandemic. These resources are up-to-date at time of publication, however the situation is changing rapidly and you should ensure that any information you use is up-to-date.
Treating haematology and oncology patients
Robert Weinkove, Zoe McQuilten, Jonathan Adler, Meera Agar, Emily Blyth, Allen Cheng, Rachel Conyers, Gabrielle Haeusler, Claire Hardie, Christopher Jackson, Steven Lane, Tom Middlemiss, Peter Mollee, Stephen Mulligan, David Ritchie, Myra Ruka, Benjamin Solomon, Jeffrey Szer, Karin Thursky, Erica Wood, Leon Worth, Michelle Yong, Monica Slavin and Ben Teh, Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance. Med J Aust. Preprint published online: 20 March 2020. https://www.mja.com.au/
John Willan, Andrew J. King, Sandy Hayes, Graham P. Collins, Andrew Peniket. Care of haematology patients in a COVID‐19 epidemic. Br J Haematol. On-line early view; first published:15 March 2020. https://doi.org/10.1111/bjh.16620
- Australian Government Department of Health Coronavirus (COVID-19) Health Alert
- Communicable Diseases Network Australia (CDNA): National Guidelines for Public Health Units: Coronavirus Disease 2019 (COVID-19)
- New Zealand Ministry of Health COVID-19 (novel coronavirus)
- John Hopkins University & Medicine: Coronavirus Resource Centre
Transfusion Medicine Resources
- Australian Red Cross Lifeblood: Coronavirus Disease 2019 (COVID-19) and safety and sufficiency of the blood supply (health professional information) and Novel Coronavirus Update (donor information)
- New Zealand Blood Service: Important information for Blood Donors regarding COVID-19 (novel coronavirus)
- ISBT Webinar: Update on the COVID-19 Coronavirus Outbreak: Blood Collection and Safety Implications. This webinar provides good general information about management of blood donors, blood centre staff, minimising the impact on blood supplies, current research, and experiences from blood centres and hospitals in China. The use of convalescent plasma or hyperimmune immunoglobulin (for therapeutic or prophylactic purposes) is also discussed. While there is little outcome data available and good quality studies are needed, some basic information is provided in some news reports. Correction: Towards the end of the discussion an incorrect statement was made about the persistence of coronaviruses on surfaces – it is actually days not hours. The speaker corrected this after the webinar and provided a reference.
- AABB: Coronavirus Resources. Tips for Hospitals: Extending the Blood Supply, and a Statement on Coronavirus and Blood Donation
- World Health Organisation (WHO): Protecting the Blood Supply During Infectious Disease Outbreaks. Guidance for National Blood Services
- NHS Blood and Transplant: Information and Updates to Help Clinical and Laboratory Staff Manage the Impact of COVID-19